PhD Student Research in Progress
Mausam Patidar: Analyzing the prescription of
anti-depressants and incidence of Depression among patients with Irritable
Bowel Syndrome using administrative claims data. Assessing the adherence of
metformin in children (age 10-18) in comparison to adults using the PharMetrics
Chong Kim: Drug Utilization Review of Proton Pump Inhibitors
and H2RA in the Colorado Medicaid Beneficiary. Retrospective landscape analysis
using Electronic Health Records to identify utilization of pharmacogenetically
validated pharmaceuticals in Colorado.
Robert Perry: I’m currently in my second year and have
really enjoyed my studies thus far. My research interests include mental health
outcomes, psychiatric drug treatment, and validation of patient reported
outcome measures. I’m currently investigating antidepressant utilization in
Irritable Bowel Syndrome and investigating methods for enhancing early
detection of opioid misuse.
David Tabano: I am currently working on my dissertation
thesis, which aims to understand the prevalence of chronic Hepatitis C, the
progression of the disease and measurable treatment outcomes in a multi-site
regional network in Colorado.
Katherine Sullivan: I am currently working on my
dissertation in which I am looking at the associations between medications
(i.e. prescription and over the counter) and Stevens-Johnson Syndrome and Toxic
Epidermal Necrolysis, which are rare adverse drug reactions.
Why CU's Pharmaceutical Outcomes Research PhD track?
Mausam Patidar: After completing my Masters, I wanted to get
into the program and be a part of the projects which could have a direct impact
on policy issues and patients outcomes. When I got the offer, I had no doubts
about joining this program where the engaging research component in this
program is evident by the outstanding faculties. This program with its
excellent infrastructure, curriculum and research platform was a perfect
academic place for my ambitions, an opportunity that will allow me to carve a
unique niche in this field.
Chong Kim: There were several factors that ultimately led me
to choose POR training program. The biggest factor was the research output from
alumni. Although individual capacity may determine the amount of research that
may be done, I felt that at least everyone had enough exposure to opportunities
to contribute in various projects that the faculty were a part of. Another
factor was the prospects for future career. Some of the alumni graduated to
take the academic route, some took on the industry route. What allowed me to be
at ease of mind was the fact that none of them had difficulty in job searching
and were doing quite well due to the opportunities (research and networking)
they had during their stay in the program. I’ve been involved in several
projects throughout my first and second semester and I know I’ve definitely
made the best choice in coming to this program based on just that.
Robert Perry: I was interested in getting into an applied
area of science related to my interests in addiction and psychiatric drug
research. I love the State of Colorado and was aware of a number of interesting
projects at UC Denver in Pharmaceutical Outcomes Research. I am glad to say it
has worked out as envisioned.
David Tabano: My academic background in economics, and I
have worked in the healthcare industry from the past seven years, first in
healthcare policy and currently in healthcare research. The POR PhD track is a
fantastic program because it blends health economics with comparative effectiveness
research so well. I chose to enroll in at University of Colorado because the
program fit my academic and professional interests so well, and because of the
awesome learning environment. The student-faculty ratio is incredibly low,
making POR faculty not only accessible but genuinely invested in their
students. The resources available to students in this program are very useful,
both for coursework and for independent research.
Katherine Sullivan: I enrolled in the POR PhD training track
because I was, and still am, interested in how pharmaceuticals influence
people's daily lives. From the broader policy level to the specific medications
that people take, pharmaceuticals have a huge impact on human health. I have
also always been interested in research at the population level. I started as
an undergraduate in Ecology studying how environmental factors, including
pharmaceuticals in the water systems, influence animal population health. After
that, I became interested in how pharmaceuticals might be influencing human
populations, which led me to the POR program at CU Anschutz, where I have
specialized in pharmacoepidemiology. The friendly faculty and smaller size of
the program also made it very easy for me to decide that the POR program was
the right fit for me.
PhD Student Research Projects